{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:44:09Z","timestamp":1792644249902,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T00:00:00Z","timestamp":1504828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/8-7(102)\/2012-ECD-II"],"award-info":[{"award-number":["5\/8-7(102)\/2012-ECD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ijpddr.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T01:30:53Z","timestamp":1507858253000},"page":"370-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Transcriptome profiling identifies genes\/pathways associated with experimental resistance to paromomycin in Leishmania donovani"],"prefix":"10.1016","volume":"7","author":[{"given":"Aditya","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasundhra","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Kumar","family":"Deep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8094-4703","authenticated-orcid":false,"given":"Ruchi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Salotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2017.10.004_bib1","doi-asserted-by":"crossref","first-page":"e1657","DOI":"10.1371\/journal.pntd.0001657","article-title":"Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis","volume":"6","author":"Bhandari","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.ijpddr.2017.10.004_bib2","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1128\/AAC.01574-13","article-title":"Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani","volume":"58","author":"Bhandari","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.23.6.835","article-title":"Roles of ribosomal binding, membrane potential and electron transport in bacterial uptake of streptomycin and gentamicin","volume":"23","author":"Bryan","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ijpddr.2017.10.004_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1365-2958.2007.05653.x","article-title":"A novel ATP-binding cassette transporter from Leishmania is involved in transport of phosphatidylcholine analogues and resistance to alkyl-phospholipids","volume":"64","author":"Castanys-Mu\u00f1oz","year":"2007","journal-title":"Mol. Microbiol."},{"issue":"10","key":"10.1016\/j.ijpddr.2017.10.004_bib5","doi-asserted-by":"crossref","first-page":"e26660","DOI":"10.1371\/journal.pone.0026660","article-title":"Paromomycin affects translation and vesicle-mediated trafficking as revealed by proteomics of paromomycin -susceptible -resistant Leishmania donovani","volume":"6","author":"Chawla","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijpddr.2017.10.004_bib6","doi-asserted-by":"crossref","first-page":"e1004689","DOI":"10.1371\/journal.ppat.1004689","article-title":"Probing the metabolic network in bloodstream-form Trypanosoma brucei using untargeted metabolomics with stable isotope labelled glucose","volume":"11","author":"Creek","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0031182007003782","article-title":"Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation","volume":"135","author":"Decuypere","year":"2008","journal-title":"Parasitology"},{"issue":"6","key":"10.1016\/j.ijpddr.2017.10.004_bib8","doi-asserted-by":"crossref","first-page":"e0005641","DOI":"10.1371\/journal.pntd.0005641","article-title":"Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increasedinfectivity and resistance to oxidative stress","volume":"11","author":"Deep","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.ijpddr.2017.10.004_bib9","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/AAC.49.5.1988-1993.2005","article-title":"Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes","volume":"49","author":"El Fadili","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/00034983.1991.11812568","article-title":"Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment","volume":"85","author":"El-On","year":"1991","journal-title":"Ann. Trop. Med. Parasit."},{"issue":"1","key":"10.1016\/j.ijpddr.2017.10.004_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4049\/jimmunol.1002175","article-title":"Leishmania inhibitor of serine peptidase prevents TLR4 activation by neutrophil elastase promoting parasite survival in murine macrophages","volume":"186","author":"Faria","year":"2011","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.ijpddr.2017.10.004_bib12","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1128\/IAI.00853-05","article-title":"Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-Induced inhibition of nitric oxide production","volume":"74","author":"Forget","year":"2006","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.ijpddr.2017.10.004_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0001664","article-title":"Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol","volume":"6","author":"Hendrickx","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.ijpddr.2017.10.004_bib14","doi-asserted-by":"crossref","first-page":"e0140139","DOI":"10.1371\/journal.pone.0140139","article-title":"Comparative fitness of a parent Leishmania donovani clinical isolate and its experimentally derived paromomycin-resistant strain","volume":"10","author":"Hendrickx","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2017.10.004_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molbiopara.2008.12.007","article-title":"Paromomycin: uptake and resistance in Leishmania donovani","volume":"164","author":"Jhingran","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"issue":"6","key":"10.1016\/j.ijpddr.2017.10.004_bib16","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1128\/AAC.00812-10","article-title":"Antimony-resistant clinical isolates of Leishmania donovani are susceptible to paromomycin and sitamaquine","volume":"55","author":"Kulshrestha","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib17","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00436-014-3755-6","article-title":"Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant Leishmania donovani","volume":"113","author":"Kulshrestha","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00436-012-2823-z","article-title":"Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani","volume":"111","author":"Kumar","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1023\/A:1012870904097","article-title":"ABC proteins of Leishmania","volume":"33","author":"Legare","year":"2001","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib20","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1128\/EC.00152-06","article-title":"Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites","volume":"5","author":"Leprohon","year":"2006","journal-title":"Eukaryot. Cell"},{"issue":"5","key":"10.1016\/j.ijpddr.2017.10.004_bib21","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/nar\/gkn1069","article-title":"Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum","volume":"37","author":"Leprohon","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/excr.1997.3500","article-title":"In vivo interference of paromomycin with mitochondrial activity of Leishmania","volume":"232","author":"Maarouf","year":"1997","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1051\/parasite\/1998052167","article-title":"Development and characterization of paromomycin-resistant Leishmania donovani promastigotes","volume":"5","author":"Maarouf","year":"1998","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2017.10.004_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/AAC.43.3.465","article-title":"Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei","volume":"43","author":"Moore","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib25","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1038\/cddis.2011.83","article-title":"Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania","volume":"2","author":"Moreira","year":"2011","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.ijpddr.2017.10.004_bib26","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4269\/ajtmh.2012.12-0022","article-title":"In vitro Antileishmanial drug susceptibility of clinical isolates from patients with Indian visceral leishmaniasis\u2013Status of Newly Introduced Drugs","volume":"87","author":"Prajapati","year":"2012","journal-title":"Am. J. Trop. Med.Hyg"},{"key":"10.1016\/j.ijpddr.2017.10.004_bib27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ijpddr.2017.10.004_bib28","doi-asserted-by":"crossref","first-page":"e0005635","DOI":"10.1371\/journal.pntd.0005635","article-title":"Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh","volume":"11","author":"Rahman","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib29","doi-asserted-by":"crossref","first-page":"e0004289","DOI":"10.1371\/journal.pntd.0004289","article-title":"Decline in clinical efficacy of oral miltefosine in treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India","volume":"9","author":"Ramesh","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib30","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, re-infection or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1471-2164-9-255","article-title":"Genome-wide gene expression profiling analysis of Leishmania major and Leishmania infantum developmental stages reveals substantial differences between the two species","volume":"9","author":"Rochette","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ijpddr.2017.10.004_bib32","doi-asserted-by":"crossref","first-page":"645203","DOI":"10.1155\/2011\/645203","article-title":"Phase 4 pharmacovigilance trial of paromomycin injection for the treatment of visceral leishmaniasis in India","volume":"2011","author":"Sinha","year":"2011","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib33","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1128\/JCM.00173-11","article-title":"Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic","volume":"49","author":"Srivastava","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, noninferiority, randomised controlled trial","volume":"377","author":"Sundar","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2017.10.004_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.10.004_bib36","series-title":"\u201cControl of the Leishmaniasis,\u201d Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniasis","author":"World Health Organisation","year":"2010"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717301069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717301069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:48:28Z","timestamp":1761922108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320717301069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2211320717301069"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2017.10.004","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptome profiling identifies genes\/pathways associated with experimental resistance to paromomycin in Leishmania donovani","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Indian Council of Medical Research-National Institute of Pathology. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}